Advertisement
Changes loom as most-popular Medigap plans face extinction

Changes loom as most-popular Medigap plans face extinction

By Bob Herman  |  June 25, 2016

A provision within the new Medicare physician payment law eliminates the most popular types of Medigap plans and therefore will lead to future Medigap enrollees paying more out of pocket for their medical care.

Editorial: Medicare Part B drug proposal deserves support

Editorial: Medicare Part B drug proposal deserves support

By Merrill Goozner  |  June 25, 2016

Medicare's first step in reining in the skyrocketing cost of specialty drugs deserves support—something it has not received from hospitals, doctors, politicians or, of course, the pharmaceutical industry, which benefits the most from the status quo.

Data Points for June 6, 2016

Data Points for June 6, 2016

By Modern Healthcare  |  June 04, 2016

Data Points for the week of June 6, 2016, covered the following topics: Rural healthcare, EMS services in rural areas, VA services in rural areas, and healthcare access in rural areas.

Commercial insurance margins offset rising Medicare losses

Commercial insurance margins offset rising Medicare losses

By Dave Barkholz  |  May 07, 2016

As hospital margins on traditional fee-for-service Medicare patients plunged deeper into the red, cost-cutting at hospitals has allowed many to make up those losses from their commercially insured clientele.

MedPAC outlines post-acute pay overhaul, backs Part D changes

By Virgil Dickson  |  April 07, 2016

The Medicare Payment Advisory Commission has completed work on a road map for overhauling how the program pays for post-acute care. The advisory panel voted to back a variety of changes to the Part D prescription drug program that could save as much as $10 billion over five years.

Change agents charge to the top

Change agents charge to the top

By David May  |  April 02, 2016

As conversations in healthcare continue to focus on quality, patient safety and a system shifting to value over volume, Modern Healthcare's 12th annual ranking of the 50 Most Influential Physician Executives and Leaders increasingly reflects the industry players charged with making it happen.

Does CMS' Part B drug reimbursement proposal usurp clinical judgment?

By Virgil Dickson  |  March 12, 2016

Medicare's plans to overhaul the way it reimburses doctors and hospitals for the more than $20 billion worth of outpatient drugs they administer each year has sharply divided the provider community. The fault lines roughly align with the stakes in the status quo.

Controversial home visits duck Medicare's radar, for now

By Bob Herman  |  February 27, 2016

The most interesting thing about the preliminary rate notice for 2017 Medicare Advantage plans may be what federal policymakers left out. The thick document made no mention of health-risk assessments, which surprised the industry.

Advertisement
Modern Healthcare Daily

Award winning coverage of healthcare business and policy news.

The Modern Healthcare app includes a personalized home screen, strong search functionality and immediate downloads from the industry's leading healthcare media brand.